- Location
treatment of cancer
"-
Bosch Kept Its FXS Combi Under Wraps Until Interpack
May 12, 2014Bosch kept its FXS Combi under wraps until interpack. This machine, Bosch gauged, deserved to be unveiled at the world's leading packaging innovations exhibition. Depending on output and container, the machine with two or five positions ...
Tags: Bosch, Pharmaceutical Packaging Equipment, Industrial Equipment, Tools
-
CEL-SCI Corporation Has Received Approval From The Medicines and Medical Device Agency
Jan 26, 2014CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment ...
-
Patients with Advanced Pancreatic Cancer May Live a Little Longer
Jan 16, 2014Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Tags: a
-
Patients with Advanced Pancreatic Cancer May Live a Little Longer
Jan 16, 2014Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
-
Roche and Molecular Partners Have Entered Into a Research Collaboration
Dec 9, 2013Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
-
Agalimmune Has Been Created to Develop Innovative Immunotherapeutics
Nov 29, 2013Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...
Tags: solid tumours, cancer treatment
-
Bioinvent International Has Secured a US Patent for Its Antibody,Discovery Technology
Nov 14, 2013BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...
-
Nuvilex Has Acquired The Exclusive Worldwide Rights
Nov 12, 2013Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the ...
Tags: Nuvilex, Live-Cell Encapsulation Technology, biotechnology, cell, gene
-
IceCure Announced First Breast Cancer Patient Using The Icesense3 Cryoablation System
Nov 12, 2013IceCure Medical has announced that the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California, treated its first breast cancer patient using the IceSense3 cryoablation system in a pilot study evaluating ...
-
Boehringer Ingelheim Has Submitted a Marketing Authorisation Application to EMA
Oct 16, 2013Boehringer Ingelheim has submitted a marketing authorisation application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedanib. Nintedanib to be used in combination with docetaxel is ...
Tags: Boehringer Ingelheim, Lung Cancer
-
CRT Has Signed a Multi-Project Alliance Agreement with TEVA
Sep 18, 2013Cancer Research Technology (CRT), Cancer Research UK's technology development arm, has signed a multi-project alliance agreement with Teva Pharmaceutical Industries (TEVA) to research and develop new cancer drugs, which will help in ...
-
Regen Signed a Licensing Deal with Benitec Biopharma for DdRNAi Gene Silencing Technology
Aug 13, 2013Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific, has signed a licensing deal with Benitec Biopharma for ddRNAi gene silencing technology to develop vaccines. Regen will apply ddRNAi to silence indoleamine 2,3 -- ...
Tags: Regen BioPharma, Medicine
-
Switzerland-Based Celgene International SáRl Has Received Approval From The EC
Jun 20, 2013Switzerland-based Celgene International Sárl has received approval from the European Commission (EC) to allow its Revlimid drug to treat patients with transfusion-dependent anaemia. While other remedial options could not yield ...
-
PharmaMar Has Selected Medidata Clinical Cloud Platform for Marine-Based Oncology Drugs
Mar 20, 2013Spanish biopharmaceutical company PharmaMar has selected Medidata Solutions' Medidata Clinical Cloud platform to accelerate clinical trials for marine-based oncology drugs. A member of the Zeltia Group and a developer of antitumor drugs ...
-
Prostate Cancer Test Study Results Are Presented by Mdxhealth
Feb 21, 2013MDxHealth has presented results from two studies of its DNA methylation-based assay at the ASCO Genitourinary Cancers Symposium 2013, held at Orlando, Florida, US from 14 - 16 February 2013. The epigenetic assay, ConfirmMDx for Prostate ...
Related Products
-
Cancer Treatment Top Quality Dihydroartemisinin
-
Industrial Gas 99.999% 5n Hydrogen Gas in 40L Cylinder
-
Oral Tablets Anti-Estrogen Raw Powder for Breast Cancer Treatment
-
Medical Portable Cancer Diabetes Treatment Pain Relief Therapy Instrument
-
High Frequency Electro Magnetic Therapy Instrument for Treatment of Cancer Prostate Constipation
-
Hospital P Type Thermoplastic Mask for Cancer Treatment Radiotherapy Pelvis Trunk Immobilization Adaptive to Klarity/Orfit Baseplate
